MOS Jumps As Analysts Hike Targets And Debt Buybacks Advance

Mosaic Company (The) stocks have been trading up by 4.63 percent amid upbeat sentiment on stronger fertilizer demand and pricing.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading MOS

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

RBC keeps an Outperform on Mosaic Company (The) with a $27 target, looking for a gradual phosphate margin recovery and better free cash flow from lower capex and a second-half working-capital reversal.
BNP Paribas lifts its Mosaic price target to $32 from $27 and stays Outperform, while the broader Street sits overweight with a mean target near $27.
Q2 2026 adjusted EPS came in at $0.13 versus $0.12 expected, a small beat that supports the recovery narrative despite weak fertilizer pricing.
Management launched and then completed up to $1.4B in tenders for notes due 2027–2029, refinancing and cutting near- to mid-term debt load.
Through Mosaic Biosciences, the company rolled out Renuvis Enzara, an enzyme-based residue product aimed at improving field conditions and equipment efficiency.

Weekly Update Aug 17 – Aug 21, 2026: On Friday, August 21, 2026 Mosaic Company (The) stock [NYSE: MOS] is trending up by 4.63%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Materials industry expert:

Analyst sentiment – positive

Mosaic’s latest quarter underscores a cyclical trough: negative EPS, EBIT margin around -6%, and trailing profit margin near -5% reflect weak phosphate/potash pricing and heavy cost absorption. Yet the balance sheet remains solid with net debt moderate (total debt-to-equity 0.54, interest coverage 6.3) and current ratio 1.3. Shares trade at only ~0.6x book and 0.6x sales, implying deep-cycle valuation. Free cash flow was negative this quarter, but working-capital unwind and lower capex should restore positive FCF into 2027.

Technically, MOS has flipped from a low‑20s consolidation to a sharp short-term uptrend: five straight sessions of higher highs and closes, from ~21.2 to ~24.4, with expanding ranges suggesting rising participation and likely rising volume. The prior congestion zone around 22 now converts to first support and a tactical stop area for new longs. Dominant trend is bullish; actionable entry is on pullbacks toward 23.00–23.20, targeting a retest of the 25.00–25.50 area near the Mizuho target.

More Breaking News

Fundamentally and versus Materials/Agriculture peers, Mosaic offers torque to fertilizer margin normalization at a discounted multiple. Analyst targets clustered around $27–32, RBC’s and BNP’s Outperform calls, and the completed $1.4B debt tenders collectively de‑risk the balance sheet and signal management conviction. New biosciences products add modest optionality but are not thesis-critical. I assign a 12–18 month target of $28, with key resistance at $27 and strong support at $21; risk/reward is favorable.

Quick Financial Overview

Mosaic Company (The) is trading in a short-term uptrend, with weekly closes pushing from roughly the low-$21s to about $24.43 over the recent data window. That move reflects a firm bid as traders react to bullish analyst calls and improving capital-structure news. Intraday, MOS shows steady grinding price action, spending most of the day between $24.40 and $24.70, with no sharp reversal. That kind of controlled upside often signals accumulation rather than a one-off squeeze.

On the income side, the latest quarter shows total revenue around $2.82B, but profitability is under pressure. EBIT margin is thin at about 0.4%, and reported net income is negative, with a basic EPS of -$0.86 despite an adjusted EPS beat at $0.13. Gross margin near 11% and a negative profit margin above -5% tell you this is still a tough part of the cycle. For traders, that means MOS is a cyclical rebound play, not a clean growth story.

Valuation and balance sheet metrics give some support to the bull case. A price-to-sales ratio of roughly 0.58 and price-to-book near 0.62 suggest MOS trades below perceived intrinsic value, which lines up with overweight ratings and targets in the high-$20s to low-$30s. Debt metrics, including total debt-to-equity of 0.54 and interest coverage around 6.3, look manageable, especially after the $1.4B debt tender that trimmed near-term maturities. The dividend yield around 3.8% adds a carry component for swing traders, but the recent negative free cash flow of about -$153M is a reminder that cash generation is still uneven.

Conclusion

Mosaic Company (The) now sits at an interesting point on the risk–reward curve. Price action shows a controlled uptrend from the low-$20s into the mid-$24s, backed by rising volume interest and tight intraday ranges. On top of that, multiple major brokers — RBC with $27 and BNP Paribas with $32 — see upside from current levels, while even a cautious Mizuho nudged its target higher to $25. For traders, that cluster of targets in the high-$20s creates a clear reference zone for swing setups.

Fundamentally, MOS is still fighting margin pressure, but the slight Q2 adjusted EPS beat and the large-scale debt tenders show a management team working both sides of the ledger: earnings and balance sheet. The new Renuvis Enzara product adds a longer-term optionality angle, even if it will not drive near-term numbers. Short-term traders should focus on whether MOS can hold above recent support in the low-$24s and push toward the $27–$28 band where analyst targets start to cluster.

For educational purposes, the key is to respect both the improving sentiment and the still-fragile margins. As I often tell my students, “When a stock like MOS trades below book with rising targets and cleaner debt, you don’t marry the story — you trade the levels and let the tape prove the thesis.” As Tim Bohen, lead trainer with StocksToTrade says, “There’s a pattern in everything; you just have to stick around long enough to see it.”

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!